{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:18:46Z","timestamp":1783423126685,"version":"3.54.6"},"reference-count":28,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Systemic inflammation and nutritional status influence cancer progression and prognosis. The C-reactive protein\u2013albumin\u2013lymphocyte (CALLY) index is a novel biomarker reflecting inflammation, immune response, and nutritional status; however, its prognostic value in metastatic hormone-sensitive prostate cancer (mHSPC) remains unclear. Methods: This retrospective multicenter cohort study included 159 patients with de novo mHSPC diagnosed between January 2018 and April 2025. Baseline CALLY, neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI) were calculated. Results: The optimal CALLY cut-off was 0.58. A low CALLY was associated with significantly shorter progression-free survival (PFS) and overall survival (OS). It correlated with higher tumor burden, higher Gleason grade, elevated prostate-specific antigen levels, and poorer performance status. In univariate analysis, a low CALLY predicted worse OS (HR 5.20; p = 0.021), although this effect was attenuated in multivariate analysis (HR 2.15; 95% CI 0.52\u20138.90; p = 0.290), and its absolute discriminatory performance in receiver operating characteristic analysis remained modest (AUC = 0.558). Complete response rates differed significantly (high-CALLY 41.7% vs. low-CALLY 5.9%, p &lt; 0.001), suggesting a potential link between baseline CALLY and treatment response. Conclusions: Among the indices evaluated, CALLY demonstrated the highest, though still modest, discriminatory ability for overall survival (AUC 0.558), and was the only marker to reach statistical significance in survival analysis. Its prognostic effect was attenuated in multivariable analysis, suggesting that CALLY reflects, rather than independently drives, the systemic consequences of high-burden disease. These findings are exploratory, and prospective validation in larger cohorts is required to determine its potential clinical utility.<\/jats:p>","DOI":"10.3390\/diagnostics16132126","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:53:46Z","timestamp":1783418026000},"page":"2126","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of Immune-Inflammatory and Nutritional Indices in Metastatic Hormone-Sensitive Prostate Cancer"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-5581","authenticated-orcid":false,"given":"Mehmet Nuri","family":"Baser","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Aydin Adnan Menderes University, 09100 Aydin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3897-3055","authenticated-orcid":false,"given":"Ahmet","family":"Baklaci","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Aydin Adnan Menderes University, 09100 Aydin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-3815","authenticated-orcid":false,"given":"Ahmet","family":"Unlu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University of Health Sciences, Antalya Education and Research Hospital, 07100 Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-9825","authenticated-orcid":false,"given":"Asim Armagan","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University of Health Sciences, Antalya Education and Research Hospital, 07100 Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynel Umut","family":"Alpsoy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Aydin Adnan Menderes University, 09100 Aydin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8876-2848","authenticated-orcid":false,"given":"Suleyman Utku","family":"Uzun","sequence":"additional","affiliation":[{"name":"Epidemiology Division, Department of Public Health, Faculty of Medicine, Pamukkale University, 20070 Denizli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilgin","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Aydin Adnan Menderes University, 09100 Aydin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref_1","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Goto, T., Mizuno, K., Sumiyoshi, T., Kita, Y., Masui, K., Ogata, T., Aizawa, R., Sawada, A., Saito, R., and Mizowaki, T. (Int. J. Clin. Oncol., 2026). Primary site- and metastasis-directed therapies in patients with metastatic prostate cancer: A narrative review, Int. J. Clin. Oncol., Epub ahead of print.","DOI":"10.1007\/s10147-026-03061-8"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Marulanda-Corzo, V., Holmes, A.N., Giri, V.K., Osborne, J.R., and Tagawa, S.T. (Eur. Urol. Focus, 2026). How will PSMAddition impact the management of prostate cancer?, Eur. Urol. Focus, in press.","DOI":"10.1016\/j.euf.2026.05.014"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12672-025-02084-3","article-title":"The prognostic role of systemic immune-inflammation index, SII, in Metastatic Castration-Resistant Prostate Cancer patients","volume":"16","author":"Uzun","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12950-016-0143-2","article-title":"Prognostic value of inflammation in prostate cancer progression and response to therapeutic: A critical review","volume":"13","author":"Sciarra","year":"2016","journal-title":"J. Inflamm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","article-title":"Prostate carcinogenesis: Inflammatory storms","volume":"20","author":"Guo","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, Z., Liu, H., Zhu, Q., Chen, J., Zhao, J., and Zeng, H. (2024). Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12593-z"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hpb.2021.06.414","article-title":"Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma","volume":"24","author":"Iida","year":"2022","journal-title":"HPB"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41598-023-51109-w","article-title":"Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery","volume":"14","author":"Feng","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1177\/00031348241248693","article-title":"Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients with Gastric Cancer","volume":"90","author":"Nakashima","year":"2024","journal-title":"Am. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: Planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.ajpath.2019.07.007","article-title":"Prostate Cancer: The Role of Inflammation and Chemokines","volume":"189","author":"Rani","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103177","DOI":"10.1016\/j.critrevonc.2020.103177","article-title":"Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies","volume":"157","author":"Michels","year":"2021","journal-title":"Crit. Rev. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1111\/febs.14524","article-title":"Cancer-related circulating and tumor-associated neutrophils\u2014Subtypes, sources and function","volume":"285","author":"Shaul","year":"2018","journal-title":"FEBS J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Patrza\u0142ek, P., Fro\u0144, A., Mielczarek, M., Karwacki, J., Lesiuk, G., Janczak, D., Nagi, K., Krajewski, W., D\u0119bi\u0144ski, P., and Szyde\u0142ko, T. (2025). Inflammatory-based prognostic indicators in prostate cancer: Evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1595000"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0148607113502674","article-title":"Prevalence of malnutrition and current use of nutrition support in patients with cancer","volume":"38","author":"Michallet","year":"2014","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijbiomac.2021.06.140","article-title":"Serum albumin levels and inflammation","volume":"184","author":"Sheinenzon","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1007\/s12094-025-03888-z","article-title":"Prognostic utility of the CALLY index in metastatic melanoma: Building a nomogram for patients on anti-PD-1 therapy","volume":"27","author":"Acar","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1159\/000509434","article-title":"Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy","volume":"98","author":"Buonerba","year":"2020","journal-title":"Oncology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2147\/IJGM.S447201","article-title":"Prognostic Value of CRP\u2013Albumin\u2013Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer","volume":"17","author":"Zhuang","year":"2024","journal-title":"Int. J. Gen. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1245\/s10434-025-18661-3","article-title":"The Prognostic Impact of C-Reactive Protein-Albumin-Lymphocyte Index (Cally Index) in Patients with Surgically Resected Non-Small-Cell Lung Cancer","volume":"33","author":"Mizota","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yang, M., Lin, S.-Q., Liu, X.-Y., Tang, M., Hu, C.-L., Wang, Z.-W., Zhang, Q., Zhang, X., Song, M.-M., and Ruan, G.-T. (2023). Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1131496"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.7150\/jca.74930","article-title":"Prognostic value of CRP-Albumin-Lymphocyte (CALLY) index in patients undergoing surgery for oral cavity cancer","volume":"13","author":"Tsai","year":"2022","journal-title":"J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2147\/JIR.S460109","article-title":"Significance of pre-treatment CALLY score combined with EBV-DNA levels for prognostication in non-metastatic nasopharyngeal cancer patients: A clinical perspective","volume":"17","author":"Jiang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cetinayak, H.O., Aydin, B., Semiz, V., Kutlu, E.A., Basan, U., and Aksoy, R.A. (2025). Prognostic value of the CALLY index in hypopharyngeal cancer treated with definitive chemoradiotherapy: A retrospective cohort study. Diagnostics, 15.","DOI":"10.3390\/diagnostics15172237"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102992","DOI":"10.1016\/j.critrevonc.2020.102992","article-title":"Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis","volume":"151","author":"Buonerba","year":"2020","journal-title":"Crit. Rev. Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:00:00Z","timestamp":1783422000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":28,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16132126"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16132126","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}